The recent development of RNA‐based therapeutics in delivering nucleic acids for gene
editing and regulating protein translation has led to the effective treatment of various …

The hepatitis C virus (HCV) causes acute and chronic hepatitis, cirrhosis, and hepatocellular
carcinoma, as well as extrahepatic manifestations such as malignant lymphoma. Currently …

Abstract Cyprinid herpesvirus type 3 (CyHV-3), also called Koi herpesvirus (KHV), which
leads to mass cyprinid mortality and enormous economic losses. To establish an infection …

The rational selection of hepatitis C virus (HCV) vaccine antigen will aid in the prevention of
future chronic liver disease burden and associated healthcare costs. We have previously …

Hepatitis C virus (HCV) is a major medical health burden and the leading cause of chronic
liver disease and cancer worldwide. More than 58 million people are chronically infected …

The remarkable impact of RNA nanomedicine during the COVID-19 pandemic has
demonstrated the expansive therapeutic potential of this field in diverse disease contexts. In …

Hepatitis C virus (HCV) is characterized by a high number of chronic cases due to an
impairment of protective innate and adaptive immune responses. Here, we examined the …

The intricate mechanisms of the immune response elicited by vaccines and the interplay
between the immune system and the central nervous system (CNS) are poorly understood …